prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype Basal, Clinical Diagnosis & History: Left breast palpable mass biopsy showed inf. ductal carcinoma. Specimens Submitted: 1: SP: Sentinel node left axilla (fs). 2: SP: Left breast lumpectomy. 3 : SP: Superior margin, left breast. 4: SP: Medial margin, left breast. 5: SP: Inferior margin, left breast. 6: SP: Lateral margin, left breast. 7: SP: Posterior pectoral fascia margin, left breast. DIAGNOSIS: 1). LYMPH NODE, SENTINEL NODE, LEFT AXILLA; RESECTION: - FOUR BENIGN LYMPH NODES (0/4) . ADDITIONAL DEEPER LEVELS AND IMMUNOSTAINS FOR CYTOKERATINS (AE1:AE3). ARE PENDING AND THE RESULTS WILL BE REPORTED IN AN ADDENDUM. 2). BREAST, LEFT; EXCISION: - INVASIVE DUCTAL CARCINOMA, NOS TYPE, HISTOLOGIC GRADE III/III (SLIGHT. OR NO TUBULE FORMATION), NUCLEAR GRADE III/III (MARKED VARIATION IN SIZE AND. SHAPE) MEASURING 1.7 CM IN LARGEST DIMENSION MICROSCOPICALLY (GROSSLY THE. TUMOR IS MEASURED AT 1.9CM). - SCANT HIGH GRADE DUCTAL CARCINOMA IN SITU (DCIS) IS ADMIXED WITH INVASIVE. CARCINOMA. - NO CALCIFICATIONS ARK IDENTIFIED IN EITHER THE INVASIVE OR IN SITU. COMPONENT. - NO VASCULAR INVASION IS NOTED. - FOR SURGICAL MARGIN STATUS PLEASE SEE PARTS 3-7. - THE NON-NEOPLASTIC BREAST TISSUE SHOWS BIOPSY SITE CHANGES. - RESULTS OF SPECIAL STAINS (ER, PR, HER2-NEU) WILL BE REPORTED IN AN. ADDENDUM. 3). BREAST, LEFT SUPERIOR MARGIN; EXCISION: - BENIGN BREAST PARENCHYMA. 4). BREAST, LEFT MEDIAL MARGIN; EXCISION: - BENIGN BREAST WITH FIBROADENOMATOUS CHANGES. Page 2 of. 5). BREAST, LEFT INFERIOR MARGIN; EXCISION: - BENIGN BREAST PARENCHYMA. 6). BREAST, LEFT LATERAL MARGIN; EXCISION: - BENIGN BREAST PARENCHYMA. 7). BREAST, LEFT POSTERIOR PECTORAL FASCIA MARGIN; EXCISION: - BENIGN BREAST PARENCHYMA. - SKELETAL MUSCLE TISSUE. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Gross Descrintion. M.D. I.D. 1) The specimen is received fresh for frozen section labeled, "Sentinel node. left axilla", and consists of four lymph nodes measuring 1.2 to 1.8 cm in. greatest dimension. All lymph nodes are bisected and entirely submitted. Summary of sections: FSCA, fscB, fscc, fscD -- lymph node frozen section control. 2.) The specimen is received fresh, labeled "Left breast lumpectomy" and. consists of an unoriented, previous incised, 3.7 x 2.2 x 1.9 cm, piece of. fibrofatty breast tissue. The specimen is entirely inked black. Serial. sectioning reveals a previously biopsied, 1.9 x 1.8 x 1.5 cm, firm, smooth. nodular bordered, pink-white mass, located 0.2 cm with inked resection. margin. The mass is partially surrounded by a 2.5 x 1.8 x 1.2 cm area of. mildly dense, focally nodular, pink-white fibrous tissue. The remaining. breast parenchyma consists of lobules of yellow adipose. A portion of tumor. has previously been submitted to TPS. The remaining specimen is. representatively submitted. Summary of sections: MT - tumor and closest tissue edge. FFT -- full face of tumor. T - tumor. RS -- present in sections of remaining fibrous tissue. .A. 3). The specimen is received fresh, labeled "superior margin left breast". and consists of a piece of fibrofatty breast tissue measuring 2.6 x 2.6 cm,. and 0.6 cm thick. A stitch marks the new margin of excision, which is inked. black. The tissue is serially sectioned and entirely submitted. Summary of sections: SS - sequential sections. 4) The specimen is received fresh, labeled "medial margin left breast" and. consists of a piece of fibrofatty breast tissue measuring 3 x 1.8 cm, and. 0.9 cm thick. A stitch marks the new margin of excision, which is inked. black. The tissue is serially sectioned and entirely submitted. Summary of sections: SS - sequential sections. 5) The specimen is received fresh, labeled "inferior margin left breast". and consists of a piece of fibrofatty breast tissue measuring 2.5 x 2.2 cm,. and 0.8 cm thick. A stitch marks the new margin of excision, which is inked. black. The tissue is serially sectioned and entirely submitted. Summary of sections: SS - seguential sections. 6) The specimen is received fresh, labeled "lateral margin left breast" and. consists of a piece of fibrofatty breast tissue measuring 3.5 x 3.2 cm, and. 1 cm thick. A stitch marks the new margin of excision, which is inked. black. The tissue is serially sectioned and entirely submitted. Summary of sections: SS - seguential sections. 7) The specimen is received fresh, labeled "posterior pectoral fascia. margin left breast fresh" and consists of a piece of fibrofatty breast. tissue measuring 2.6 x 1.6 cm, and 0.7 cm thick. A stitch marks the new. margin of excision, which is inked black. The tissue is serially sectioned. and entirely submitted. Summary of sections: SS - sequential sections. Summary of Sections: Part 1: SP: Sentinel node left axilla (fs). Block. Sect. Site. PCs. faca. 2. ,1. fscB. 2. 1. fscc. 2. 1. fscD. 2. Part 2: SP: Left breast lumpectomy. Block. Sect. Site. PCs. 1. FFT. 1. 1. MT. 1. 2. RS. 4. 3. T. 5. Part 3: SP: Superior margin, left breast. Block. Sect. Site. PCs. 4. SS. 7. Part 4: SP: Medial margin, left breast. Block. Sect. Site. PCs. 4. SS. 8. Part 5 : SP: Inferior margin, left breast. Block. Sect. Site. PCs. 5. SS. 7. Part 6: SP: Lateral margin, left breast. Block. Sect. Site. PCs. 6. SS. 8. Part 7: SP: Posterior pectoral fascia margin, left breast. Block. Sect. Site. PCs. 3. SS. 7. Procedures/Addenda: Addendum. Date Complete: M.D. Addendum Diagnosis. PART #2. LEFT BREAST: Immunohistochemical stains were performed on formalin-fixed - tissue with the. following results for invasive carcinoma (block 2) : ESTROGEN RECEPTOR. 0% nuclear staining. PROGESTERONE RECEPTOR. 0% nuclear staining. HER2 (. .Negative (0 ). (08 of invasive tumor cells exhibit complete membranous staining;. Uhiformity of staining: absent;. Homogeneous, dark circumferential pattern: absent). Comment: Controls are satisfactory. PATHWAY anti-HER-2/neu is an. FDA-approved rabbit monoclonal primary antibody (clone 4B5) directed against. the internal domain of the c-erbB-2 oncoprotein (HER2) for. immunohistochemical detection of HER2 protein overexpression in breast. cancer tissue routinely processed for histologic evaluation. The HER2 test. results are reported in accordance with the ASCO/CAP guideline. recormmendations for HER2 testing in breast cancer (J Clin Oncol 2007;. 25 (1) :118-145) The ER and PR rabbit monoclonal antibodies are also FDA. approved. 1. SENTINEL LYMPH NODE (S), LEFT AXILLA (PART 1). Additional H/E stained sections and immunohistochemical stains for. cytokeratins (AE1:AE3) show no evidence of metastatic tumor. Some of the immunohistochemistry and ISH tests develonad and thain. performance characteristics were determined by. They have not been cleared or approved by the US Food and Drug. Administration. The FDA has determined that such clearance or approval is. not necessary. These tests are used for clinical purposes. They should not. be regarded as investigational or for research. This laboratory is certified. under the Clinical Laboratory Improvement Amendments of 1988 (CLIA . 88). as. qualified to perform high complexity clinical laboratory testing. M.D. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the tissue sample. examined at the time of the intraoperative consultation. 1). FROZEN SECTION DIAGNOSIS: SP: SENTINEL NODE LEFT AXILLA (FS) : BENIGN LYMPH NODES. PERMANENT DIAGNOSIS: SAME. Note: The diagnoses given in this section pertain only to the tissue sample. examined at the time of the intraoperative consultation. i). FROZEN SECTION DIAGNOSIS: SP: SENTINEL NODE LEFT AXILLA (FS) : BENIGN LYMPH NODES. PERMANENT DIAGNOSIS: SAME.

expanded version (tokens=2652) : 
 The breast pathology report provides the following information:

Clinical Diagnosis & History: Left breast palpable mass biopsy showed inf. ductal carcinoma.

Specimens Submitted:
1: SP: Sentinel node left axilla (fs).
2: SP: Left breast lumpectomy.
3 : SP: Superior margin, left breast.
4: SP: Medial margin, left breast.
5: SP: Inferior margin, left breast.
6: SP: Lateral margin, left breast.
7: SP: Posterior pectoral fascia margin, left breast.

DIAGNOSIS:
1. LYMPH NODE, SENTINEL NODE, LEFT AXILLA; RESECTION: - FOUR BENIGN LYMPH NODES (0/4)
2. BREAST, LEFT; EXCISION:
- INVASIVE DUCTAL CARCINOMA, NOS TYPE, HISTOLOGIC GRADE III/III (SLIGHT. OR NO TUBULE FORMATION), NUCLEAR GRADE III/III (MARKED VARIATION IN SIZE AND. SHAPE)
- SCANT HIGH GRADE DUCTAL CARCINOMA IN SITU (DCIS) IS ADMIXED WITH INVASIVE. CARCINOMA.
- NO CALCIFICATIONS ARK IDENTIFIED IN EITHER THE INVASIVE OR IN SITU. COMPONENT.
- NO VASCULAR INVASION IS NOTED.
- FOR SURGICAL MARGIN STATUS PLEASE SEE

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=2770) : 
 Left breast lumpectomy demonstrated invasive ductal carcinoma (NOS type) with high nuclear grade and scant DCIS admixture. No calcifications or vascular invasion were identified. Margins were not specified. In the sentinel node, four benign lymph nodes were identified. Receptor status is pending, and further testing has been deferred to an addendum.

